Myasthenia gravis (MG) disrupts signals between your ... with a CT scan or MRI. These detailed pictures can show if you have a thymoma – a tumor in the thymus gland. Pulmonary function test.

Telitacicept is a dual-targeting agent that attaches to and blocks the effects of 2 key signaling proteins, B-lymphocyte ...

Your doctor can get a better picture of how things are going for you with notes on how your symptoms show up over time. They may give you a form to fill out called the Myasthenia Gravis Activities ...

a great majority of which did not have any evidence of myasthenia gravis. In none of these cases was there any reduction of the exophthalmos whatsoever. Your case, consequently, represents the ...

Excitingly, in myasthenia [gravis], we have entered the advanced therapy era with the approval of the complement inhibitors starting in 2017, and now, more recently, the FcRn [neonatal Fc receptor ...

The FDA has approved Alexion's Soliris for use in patients with treatment resistant generalised Myasthenia gravis (gMG), making ... These patients represent approximately 5-10% of all patients ...

SAVANNAH, GEORGIA — One patient with autoimmune myasthenia gravis (MG) has a niece with the same diagnosis, and at least one of his other close relatives may have it too. Another patient with MG ...

During last Monday’s meeting, the Matagorda County Commissioners Court proclaimed June as Myasthenia Gravis Awareness Month, ...

“Inebilizumab is unique in that it targets specific B-cells which are upstream immunopathogenic disease drivers and represents a novel approach to the management of myasthenia gravis,” Nowak ...